S'abonner

Age-associated distribution of normal B-cell and plasma cell subsets in peripheral blood - 06/06/18

Doi : 10.1016/j.jaci.2018.02.017 
Elena Blanco, MSc a, Martín Pérez-Andrés, PhD a, Sonia Arriba-Méndez, MD, PhD b, Teresa Contreras-Sanfeliciano, MD c, Ignacio Criado, MSc a, Ondrej Pelak, PhD d, Ana Serra-Caetano, MSc e, Alfonso Romero, MD f, Noemí Puig, MD, PhD g, Ana Remesal, MD b, Juan Torres Canizales, MD h, Eduardo López-Granados, MD, PhD h, Tomas Kalina, MD, PhD d, Ana E. Sousa, MD, PhD f, Menno van Zelm, PhD i, j, Mirjam van der Burg, PhD j, Jacques J.M. van Dongen, MD, PhD k, Alberto Orfao, MD, PhD a,
on behalf of the

EuroFlow PID group

a Department of Medicine, Cancer Research Centre (IBMCC, USAL-CSIC), Cytometry Service (NUCLEUS), University of Salamanca (USAL), the Institute of Biomedical Research of Salamanca (IBSAL), Salamanca, and the Biomedical Research Networking Centre Consortium of Oncology (CIBERONC) Instituto de Salud Carlos III, Madrid, Spain 
b Servicio de Pediatría, Hospital Universitario de Salamanca, Salamanca, Spain 
c Servicio de Bioquímica Clínica, Hospital Universitario de Salamanca, Salamanca, Spain 
g Servicio de Hematología, Hospital Universitario de Salamanca, Salamanca, Spain 
d CLIP, Department of Haematology/Oncology, 2nd Faculty of Medicine, Charles University, Prague, Czech Republic 
e Instituto de Medicina Molecular, Faculdade de Medicina, Universidade de Lisboa, Lisbon, Portugal 
f Centro de Salud Miguel Armijo, Sanidad de Castilla y León (SACYL), Castilla y León, Salamanca, Spain 
h Departamento de Inmunología, Hospital Universitario La Paz, Madrid, Spain 
i Department of Immunology and Pathology, Monash University and Alfred Hospital, Melbourne, Australia 
j Department of Immunology, Erasmus University Medical Center (Erasmus MC), Rotterdam, The Netherlands 
k Department of Immunohematology and Blood Transfusion, Leiden University Medical Center, Leiden, The Netherlands 

Corresponding author: Alberto Orfao, MD, PhD, Department of Medicine, Cancer Research Center, University of Salamanca, Paseo de la Universidad de Coimbra s/n, 37007 Salamanca, Spain.Department of MedicineCancer Research CenterUniversity of SalamancaPaseo de la Universidad de Coimbra s/nSalamanca37007Spain

Abstract

Background

Humoral immunocompetence develops stepwise throughout life and contributes to individual susceptibility to infection, immunodeficiency, autoimmunity, and neoplasia. Immunoglobulin heavy chain (IgH) isotype serum levels can partly explain such age-related differences, but their relationship with the IgH isotype distribution within memory B-cell (MBC) and plasma cell (PCs) compartments remains to be investigated.

Objective

We studied the age-related distribution of MBCs and PCs expressing different IgH isotypes in addition to the immature/transitional and naive B-cell compartments.

Methods

B-cell and PC subsets and plasma IgH isotype levels were studied in cord blood (n = 19) and peripheral blood (n = 215) from healthy donors aged 0 to 90 years by using flow cytometry and nephelometry, respectively.

Results

IgH-switched MBCs expressing IgG1, IgG2, IgG3, IgA1, and IgA2 were already detected in cord blood and newborns at very low counts, whereas CD27+IgM++IgD+ MBCs only became detectable at 1 to 5 months and remained stable until 2 to 4 years, and IgD MBCs peaked at 2 to 4 years, with both populations decreasing thereafter. MBCs expressing IgH isotypes of the second immunoglobulin heavy chain constant region (IGHC) gene block (IgG1, IgG3, and IgA1) peaked later during childhood (2-4 years), whereas MBCs expressing third IGHC gene block immunoglobulin isotypes (IgG2, IgG4, and IgA2) reached maximum values during adulthood. PCs were already detected in newborns, increasing in number until 6 to 11 months for IgM, IgG1, IgG2, IgG3, IgA1, and IgA2; until 2 to 4 years for IgD; and until 5 to 9 years for IgG4 and decreasing thereafter. For most IgH isotypes (except IgD and IgG4), maximum plasma levels were reached after PC and MBC counts peaked.

Conclusions

PC counts reach maximum values early in life, followed by MBC counts and plasma IgH isotypes. Importantly, IgH isotypes from different IGHC gene blocks show different patterns, probably reflecting consecutive cycles of IgH isotype switch recombination through life.

Le texte complet de cet article est disponible en PDF.

Graphical abstract




Le texte complet de cet article est disponible en PDF.

Key words : Immunoglobulins, IgH isotype, subclass, memory B cells, plasma cells, flow cytometry, reference ranges, normal B cells, age-related values

Abbreviations used : BM, CB, IgH, IGHC, MBC, PB, PC, RT, sm, SSC


Plan


 E.B. was supported by a grant from Junta de Castilla y León (Fondo Social Europeo, ORDEN EDU/346/2013, Valladolid, Spain). This work was supported by the CB16/12/00400 grant (CIBERONC, Instituto de Salud Carlos III, Ministerio de Economía y Competitividad, Madrid, Spain, and FONDOS FEDER) and the FIS PI12/00905-FEDER grant from the Fondo de Investigaciones Sanitarias of Instituto de Salud Carlos III (Madrid, Spain). O.P. and T.K. were supported by the Ministry of Education, Youth and Sports (NPU I no. LO1604 and 15-28541A). The coordination and innovation processes of this study were supported by the EuroFlow Consortium.
 Disclosure of potential conflict of interest: E. Blanco, M. Pérez-Andrés, E. López-Granados, T. Kalina, M. van Zelm, M. van der Burg, J. J. M. van Dongen, and A. Orfao each report being one of the inventors on the EuroFlow-owned patent PCT/NL 2015/050762 (Diagnosis of primary immunodeficiencies), which is licensed to Cytognos, a company that pays royalties to the EuroFlow Consortium. M. van Zelm reports grants from the NHMRC and has a patent issued (EP 2780711 B1). J. J. M. van Dongen and A. Orfao report an Educational Services Agreement from BD Biosciences The rest of the authors declare that they have no relevant conflicts of interest.


© 2018  The Authors. Publié par Elsevier Masson SAS. Tous droits réservés.
Ajouter à ma bibliothèque Retirer de ma bibliothèque Imprimer
Export

    Export citations

  • Fichier

  • Contenu

Vol 141 - N° 6

P. 2208 - juin 2018 Retour au numéro
Article précédent Article précédent
  • Sialic acid–binding immunoglobulin-like lectin 8 (Siglec-8) is an activating receptor mediating ?2-integrin–dependent function in human eosinophils
  • Daniela J. Carroll, Jeremy A. O'Sullivan, David B. Nix, Yun Cao, Michael Tiemeyer, Bruce S. Bochner
| Article suivant Article suivant
  • CD8+CD28?CD127loCD39+ regulatory T-cell expansion: A new possible pathogenic mechanism for HIV infection?
  • Daniela Fenoglio, Chiara Dentone, Alessio Signori, Antonio Di Biagio, Alessia Parodi, Francesca Kalli, Giorgia Nasi, Monica Curto, Giovanni Cenderello, Pasqualina De Leo, Valentina Bartolacci, Giancarlo Orofino, Laura Ambra Nicolini, Lucia Taramasso, Edoardo Fiorillo, Valeria Orrù, Paolo Traverso, Bianca Bruzzone, Federico Ivaldi, Eugenio Mantia, Michele Guerra, Simone Negrini, Mauro Giacomini, Sanjay Bhagani, Gilberto Filaci

Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.

Déjà abonné à cette revue ?

Mon compte


Plateformes Elsevier Masson

Déclaration CNIL

EM-CONSULTE.COM est déclaré à la CNIL, déclaration n° 1286925.

En application de la loi nº78-17 du 6 janvier 1978 relative à l'informatique, aux fichiers et aux libertés, vous disposez des droits d'opposition (art.26 de la loi), d'accès (art.34 à 38 de la loi), et de rectification (art.36 de la loi) des données vous concernant. Ainsi, vous pouvez exiger que soient rectifiées, complétées, clarifiées, mises à jour ou effacées les informations vous concernant qui sont inexactes, incomplètes, équivoques, périmées ou dont la collecte ou l'utilisation ou la conservation est interdite.
Les informations personnelles concernant les visiteurs de notre site, y compris leur identité, sont confidentielles.
Le responsable du site s'engage sur l'honneur à respecter les conditions légales de confidentialité applicables en France et à ne pas divulguer ces informations à des tiers.


Tout le contenu de ce site: Copyright © 2024 Elsevier, ses concédants de licence et ses contributeurs. Tout les droits sont réservés, y compris ceux relatifs à l'exploration de textes et de données, a la formation en IA et aux technologies similaires. Pour tout contenu en libre accès, les conditions de licence Creative Commons s'appliquent.